Cargando…
Anticancer efficacy of a nitric oxide‐modified derivative of bifendate against multidrug‐resistant cancer cells
The development of multidrug resistance (MDR) not only actively transports a wide range of cytotoxic drugs across drug transporters but is also a complex interaction between a number of important cellular signalling pathways. Nitric oxide donors appear to be a new class of anticancer therapeutics fo...
Autores principales: | Ren, Zhiguang, Gu, Xiaoke, Lu, Bin, Chen, Yaqiong, Chen, Guojiang, Feng, Jiannan, Lin, Jizhen, Zhang, Yihua, Peng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882976/ https://www.ncbi.nlm.nih.gov/pubmed/26864945 http://dx.doi.org/10.1111/jcmm.12796 |
Ejemplares similares
-
Study on four polymorphs of bifendate based on X-ray crystallography
por: Nie, Jinju, et al.
Publicado: (2016) -
Multiomics analysis profile acute liver injury module clusters to compare the therapeutic efficacy of bifendate and muaddil sapra
por: Talifu, Ainiwaer, et al.
Publicado: (2019) -
Co-administration of berberine/gypenosides/bifendate ameliorates metabolic disturbance but not memory impairment in type 2 diabetic mice
por: Zhang, Meng, et al.
Publicado: (2021) -
Anticancer potential of nitric oxide (NO) in neuroblastoma treatment
por: Gordon, Jenna L., et al.
Publicado: (2021) -
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
por: Mintz, Joel, et al.
Publicado: (2021)